Litcius/Paper detail

A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study

Abdulazeez Salawu, Aaron R. Hansen, Anna Spreafico, Esmail Mutahar Al-Ezzi, Sheila Webster, Philippe L. Bédard, Jeffrey Doi, Lisa Wang, Lillian L. Siu, Albiruni R. Abdul Razak

2022Targeted Oncology11 citationsDOI

Topics & Concepts

MedicineAfatinibInternal medicineOncologyResponse Evaluation Criteria in Solid TumorsNeratinibCancerEpidermal growth factor receptorBreast cancerClinical trialErlotinibPhases of clinical researchTrastuzumabHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study | Litcius